Related references
Note: Only part of the references are listed.Molecular subclusters of follicular lymphoma: a report from the United Kingdom?s Haematological Malignancy Research Network
Simon Crouch et al.
BLOOD ADVANCES (2022)
Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma
Grace M. Pindzola et al.
BLOOD (2022)
Pathogenesis of follicular lymphoma: genetics to the microenvironment to clinical translation
Emil Kumar et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Past, present and future of prognostic scores in follicular lymphoma
Pablo Mozas et al.
BLOOD REVIEWS (2021)
Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study
Emmanuel Bachy et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era
Alfredo Rivas-Delgado et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
COSMIC: somatic cancer genetics at high-resolution
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2017)
PIM kinases 1, 2 and 3 in intracellular LIF signaling, proliferation and apoptosis in trophoblastic cells
Stella Mary Photini et al.
EXPERIMENTAL CELL RESEARCH (2017)
EVALUATION OF CLINICOGENETIC RISK MODELS FOR OUTCOME OF FOLLICULAR LYMPHOMA PATIENTS IN THE PRIMA TRIAL
S. Huet et al.
HEMATOLOGICAL ONCOLOGY (2017)
Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group
Sara Alonso-Alvarez et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
Jessica Okosun et al.
NATURE GENETICS (2016)
Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study
Robert Kridel et al.
PLOS MEDICINE (2016)
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
Carla Casulo et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation
Michael R. Green et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Mechismo: predicting the mechanistic impact of mutations and modifications on molecular interactions
Matthew J. Betts et al.
NUCLEIC ACIDS RESEARCH (2015)
Targetable Activating Mutations are Very Frequent in GCB and ABC Diffuse Large B-Cell Lymphoma
Elodie Bohers et al.
GENES CHROMOSOMES & CANCER (2014)
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma
Jessica Okosun et al.
NATURE GENETICS (2014)
Genetics of Follicular Lymphoma Transformation
Laura Pasqualucci et al.
CELL REPORTS (2014)
The immunobiology of Ro52 (TRIM21) in autoimmunity: A critical review
Vilija Oke et al.
JOURNAL OF AUTOIMMUNITY (2012)
PepSite: prediction of peptide-binding sites from protein surfaces
Leonardo G. Trabuco et al.
NUCLEIC ACIDS RESEARCH (2012)
Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells
J. Wang et al.
ONCOGENE (2012)
Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles
Heike Horn et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
Laura Pasqualucci et al.
NATURE (2011)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
High Resolution Analysis of Follicular Lymphoma Genomes Reveals Somatic Recurrent Sites of Copy-Neutral Loss of Heterozygosity and Copy Number Alterations that Target Single Genes
K-John J. Cheung et al.
GENES CHROMOSOMES & CANCER (2010)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
International network of cancer genome projects
Thomas J. Hudson et al.
NATURE (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
Prognostic Significance of Secondary Cytogenetic Alterations in Follicular Lymphomas
Nathalie A. Johnson et al.
GENES CHROMOSOMES & CANCER (2008)
Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study
Eric D. Hsi et al.
LEUKEMIA & LYMPHOMA (2008)
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
Georg Lenz et al.
SCIENCE (2008)
Cutting edge: Autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages
Hee Jeong Kong et al.
JOURNAL OF IMMUNOLOGY (2007)
Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1
U Maurer et al.
MOLECULAR CELL (2006)
MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-κB activation
TJ Che et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Essential role of Src-family protein tyrosine kinases in NF-κB activation during B cell development
K Saijo et al.
NATURE IMMUNOLOGY (2003)